“Risk of Hepatitis B Reactivation in Rheumatic Patients Receiving Tocilizumab Treatment”. Annals of Medical Research, vol. 32, no. 11, Nov. 2025, pp. 512-7, http://www.annalsmedres.org/index.php/aomr/article/view/4880.